RecruitingNot Applicable

Hyperbaric Oxygen Therapy for Men Suffering From Infertility Due to Oligospermia.

Israel15 participantsStarted 2024-01-20

Plain-language summary

Infertility in a couple is defined as the inability to achieve conception despite one year of frequent, unprotected intercourse. Infertility affects approximately 12% of couples attempting to conceive. The goal of this study is to explore the potential beneficial effect of HBOT on sperm count of infertile male due to oligospermia.

Who can participate

Age range21 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age above 21 years
✓. At least two sperm examination showing oligospermia (\<15·106 sperm/mL)
✓. Diagnosis of idiopathic oligospermia.
✓. Subject willing and able to read, understand and sign an informed consent

Exclusion criteria

✕. Inability to attend scheduled clinic visits and/or comply with the study protocol
✕. Active malignancy
✕. Previous treatment with chemotherapy and/or radiation therapy
✕. Substance use at baseline
✕. Severe or unstable physical disorders or major cognitive deficits at baseline
✕. HBOT for any reason prior to study enrolment
✕. Chest pathology incompatible with pressure changes (including moderate to severe asthma)
✕. Ear or Sinus pathology incompatible with pressure changes

What they're measuring

Sperm count

Timeframe: At baseline, 3 months

Trial details

NCT IDNCT05842239

SponsorAssaf-Harofeh Medical Center

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2030-12-01

Contact for this trial

Shachar Finci, MD

97289542395 shacharf@shamir.gov.il

View on ClinicalTrials.gov More Oligospermia trials